An increase in insulin sensitivity and basal beta-cell function in diabetic subjects treated with pioglitazone in a placebo-controlled randomized study.
AIMS: To investigate the effect of treatment with pioglitazone on beta-cell function and insulin sensitivity in Type 2 diabetes. METHODS: Thirty subjects with diet-controlled Type 2 diabetes were randomized to 3 months treatment with pioglitazone (n = 19) or placebo (n = 11). All subjects underwent...
Main Authors: | Wallace, T, Levy, J, Matthews, DR |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2004
|
Similar Items
-
Pioglitazone increases whole body insulin sensitivity in obese, insulin-resistant rhesus monkeys.
by: Effie Tozzo, et al.
Published: (2015-01-01) -
The Insulin-Sensitizer Pioglitazone Remodels Adipose Tissue Phospholipids in Humans
by: Juan P. Palavicini, et al.
Published: (2021-12-01) -
Pioglitazone and metformin.
by: Hill, N, et al.
Published: (2007) -
Pioglitazone/metformin - Viewpoint
by: Matthews, DR
Published: (2006) -
Application of structural model of glucose-insulin relations to assess beta-cell function and insulin sensitivity.
by: Turner, R, et al.
Published: (1990)